$22.06
+0.14 (+0.64%)
Open$22.11
Previous Close$21.92
Day High$22.19
Day Low$22.04
52W High$24.01
52W Low$16.52
Volume—
Avg Volume833.4K
Market Cap1.77B
P/E Ratio13.88
EPS$1.26
SectorPharmaceuticals
Analyst Ratings
Strong Buy
11 analysts
Price Target
+77.5% upside
Current
$22.06
$22.06
Target
$39.16
$39.16
$23.99
$39.16 avg
$41.33
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 364.61M | 375.54M | 296.49M |
| Net Income | 23.78M | 22.04M | 100.45M |
| Profit Margin | 6.5% | 6.2% | 33.9% |
| EBITDA | 192.89M | 188.74M | 161.71M |
| Free Cash Flow | — | — | 84.32M |
| Rev Growth | -2.9% | -2.9% | +12.4% |
| Debt/Equity | 0.65 | 0.65 | 0.49 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |